nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—CELA1—pancreatic cancer	0.616	1	CbGaD
Telaprevir—ORM1—Erlotinib—pancreatic cancer	0.0509	0.243	CbGbCtD
Telaprevir—CELA1—ventral pancreatic duct—pancreatic cancer	0.0483	0.69	CbGeAlD
Telaprevir—ALB—Erlotinib—pancreatic cancer	0.0214	0.102	CbGbCtD
Telaprevir—ALB—Irinotecan—pancreatic cancer	0.0193	0.0924	CbGbCtD
Telaprevir—ALB—Fluorouracil—pancreatic cancer	0.0186	0.0887	CbGbCtD
Telaprevir—ABCB1—Tamoxifen—pancreatic cancer	0.0132	0.063	CbGbCtD
Telaprevir—ABCB1—Gemcitabine—pancreatic cancer	0.0114	0.0542	CbGbCtD
Telaprevir—ABCB1—Erlotinib—pancreatic cancer	0.0112	0.0535	CbGbCtD
Telaprevir—ABCB1—Irinotecan—pancreatic cancer	0.0101	0.0484	CbGbCtD
Telaprevir—CYP3A4—Tamoxifen—pancreatic cancer	0.0079	0.0377	CbGbCtD
Telaprevir—ABCB1—Docetaxel—pancreatic cancer	0.00742	0.0354	CbGbCtD
Telaprevir—ABCB1—Sunitinib—pancreatic cancer	0.00738	0.0353	CbGbCtD
Telaprevir—CYP3A4—Erlotinib—pancreatic cancer	0.00671	0.0321	CbGbCtD
Telaprevir—CYP3A4—Irinotecan—pancreatic cancer	0.00606	0.029	CbGbCtD
Telaprevir—ABCB1—Doxorubicin—pancreatic cancer	0.00553	0.0264	CbGbCtD
Telaprevir—CYP3A4—Docetaxel—pancreatic cancer	0.00444	0.0212	CbGbCtD
Telaprevir—ORM1—bile—pancreatic cancer	0.00443	0.0633	CbGeAlD
Telaprevir—CYP3A4—Sunitinib—pancreatic cancer	0.00442	0.0211	CbGbCtD
Telaprevir—CYP3A4—Doxorubicin—pancreatic cancer	0.00331	0.0158	CbGbCtD
Telaprevir—CELA1—pancreas—pancreatic cancer	0.00323	0.0461	CbGeAlD
Telaprevir—CTSK—gall bladder—pancreatic cancer	0.00235	0.0336	CbGeAlD
Telaprevir—CTSS—gall bladder—pancreatic cancer	0.00206	0.0294	CbGeAlD
Telaprevir—CMA1—digestive system—pancreatic cancer	0.00144	0.0205	CbGeAlD
Telaprevir—CTSS—islet of Langerhans—pancreatic cancer	0.00135	0.0193	CbGeAlD
Telaprevir—ORM1—gall bladder—pancreatic cancer	0.00123	0.0176	CbGeAlD
Telaprevir—CTSK—pancreas—pancreatic cancer	0.00108	0.0155	CbGeAlD
Telaprevir—ALB—gall bladder—pancreatic cancer	0.00108	0.0154	CbGeAlD
Telaprevir—CTSS—pancreas—pancreatic cancer	0.000949	0.0136	CbGeAlD
Telaprevir—CTSK—digestive system—pancreatic cancer	0.000925	0.0132	CbGeAlD
Telaprevir—CTSS—digestive system—pancreatic cancer	0.000811	0.0116	CbGeAlD
Telaprevir—Stevens-Johnson syndrome—Tamoxifen—pancreatic cancer	0.000344	0.00526	CcSEcCtD
Telaprevir—Infestation NOS—Erlotinib—pancreatic cancer	0.000343	0.00525	CcSEcCtD
Telaprevir—Infestation—Erlotinib—pancreatic cancer	0.000343	0.00525	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Erlotinib—pancreatic cancer	0.00034	0.00521	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Docetaxel—pancreatic cancer	0.000333	0.00509	CcSEcCtD
Telaprevir—Hepatobiliary disease—Erlotinib—pancreatic cancer	0.000325	0.00497	CcSEcCtD
Telaprevir—Oral candidiasis—Epirubicin—pancreatic cancer	0.000321	0.00491	CcSEcCtD
Telaprevir—Oedema peripheral—Tamoxifen—pancreatic cancer	0.000307	0.00469	CcSEcCtD
Telaprevir—Urinary tract disorder—Erlotinib—pancreatic cancer	0.000304	0.00465	CcSEcCtD
Telaprevir—Urethral disorder—Erlotinib—pancreatic cancer	0.000302	0.00462	CcSEcCtD
Telaprevir—Blood creatinine increased—Irinotecan—pancreatic cancer	0.000298	0.00455	CcSEcCtD
Telaprevir—Oral candidiasis—Doxorubicin—pancreatic cancer	0.000297	0.00455	CcSEcCtD
Telaprevir—Infestation NOS—Sunitinib—pancreatic cancer	0.000297	0.00455	CcSEcCtD
Telaprevir—Infestation—Sunitinib—pancreatic cancer	0.000297	0.00455	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.000295	0.00451	CcSEcCtD
Telaprevir—Erythema multiforme—Tamoxifen—pancreatic cancer	0.000295	0.0045	CcSEcCtD
Telaprevir—Erythema multiforme—Erlotinib—pancreatic cancer	0.000291	0.00446	CcSEcCtD
Telaprevir—Blood creatinine increased—Gemcitabine—pancreatic cancer	0.00029	0.00443	CcSEcCtD
Telaprevir—Hypokalaemia—Irinotecan—pancreatic cancer	0.000289	0.00442	CcSEcCtD
Telaprevir—Candida infection—Docetaxel—pancreatic cancer	0.000289	0.00442	CcSEcCtD
Telaprevir—Eye disorder—Erlotinib—pancreatic cancer	0.000288	0.0044	CcSEcCtD
Telaprevir—Hypokalaemia—Gemcitabine—pancreatic cancer	0.000282	0.00431	CcSEcCtD
Telaprevir—Hepatobiliary disease—Sunitinib—pancreatic cancer	0.000281	0.0043	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Gemcitabine—pancreatic cancer	0.000279	0.00426	CcSEcCtD
Telaprevir—Malnutrition—Erlotinib—pancreatic cancer	0.000268	0.0041	CcSEcCtD
Telaprevir—Dysgeusia—Tamoxifen—pancreatic cancer	0.000266	0.00406	CcSEcCtD
Telaprevir—Urinary tract disorder—Sunitinib—pancreatic cancer	0.000264	0.00403	CcSEcCtD
Telaprevir—Oedema peripheral—Sunitinib—pancreatic cancer	0.000263	0.00402	CcSEcCtD
Telaprevir—Urethral disorder—Sunitinib—pancreatic cancer	0.000262	0.004	CcSEcCtD
Telaprevir—Eosinophilia—Fluorouracil—pancreatic cancer	0.00026	0.00398	CcSEcCtD
Telaprevir—Erythema multiforme—Sunitinib—pancreatic cancer	0.000252	0.00386	CcSEcCtD
Telaprevir—Anaemia—Tamoxifen—pancreatic cancer	0.000251	0.00383	CcSEcCtD
Telaprevir—Eye disorder—Sunitinib—pancreatic cancer	0.000249	0.00381	CcSEcCtD
Telaprevir—Syncope—Erlotinib—pancreatic cancer	0.000241	0.00368	CcSEcCtD
Telaprevir—ABCB1—islet of Langerhans—pancreatic cancer	0.000238	0.0034	CbGeAlD
Telaprevir—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.000236	0.00362	CcSEcCtD
Telaprevir—Loss of consciousness—Erlotinib—pancreatic cancer	0.000236	0.00361	CcSEcCtD
Telaprevir—Infestation NOS—Fluorouracil—pancreatic cancer	0.000235	0.00359	CcSEcCtD
Telaprevir—Infestation—Fluorouracil—pancreatic cancer	0.000235	0.00359	CcSEcCtD
Telaprevir—Malnutrition—Sunitinib—pancreatic cancer	0.000232	0.00355	CcSEcCtD
Telaprevir—Dysgeusia—Sunitinib—pancreatic cancer	0.000227	0.00348	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.000227	0.00347	CcSEcCtD
Telaprevir—Rectal haemorrhage—Epirubicin—pancreatic cancer	0.000226	0.00346	CcSEcCtD
Telaprevir—Hepatobiliary disease—Gemcitabine—pancreatic cancer	0.000226	0.00345	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Epirubicin—pancreatic cancer	0.000224	0.00343	CcSEcCtD
Telaprevir—Hyperuricaemia—Epirubicin—pancreatic cancer	0.00022	0.00336	CcSEcCtD
Telaprevir—Infection—Tamoxifen—pancreatic cancer	0.00022	0.00336	CcSEcCtD
Telaprevir—Infection—Erlotinib—pancreatic cancer	0.000218	0.00333	CcSEcCtD
Telaprevir—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.000217	0.00331	CcSEcCtD
Telaprevir—Shock—Erlotinib—pancreatic cancer	0.000215	0.00329	CcSEcCtD
Telaprevir—Nervous system disorder—Erlotinib—pancreatic cancer	0.000215	0.00328	CcSEcCtD
Telaprevir—Anaemia—Sunitinib—pancreatic cancer	0.000215	0.00328	CcSEcCtD
Telaprevir—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000214	0.00328	CcSEcCtD
Telaprevir—Skin disorder—Erlotinib—pancreatic cancer	0.000213	0.00325	CcSEcCtD
Telaprevir—Urinary tract disorder—Gemcitabine—pancreatic cancer	0.000211	0.00323	CcSEcCtD
Telaprevir—Oedema peripheral—Gemcitabine—pancreatic cancer	0.000211	0.00323	CcSEcCtD
Telaprevir—Urethral disorder—Gemcitabine—pancreatic cancer	0.00021	0.00321	CcSEcCtD
Telaprevir—Rectal haemorrhage—Doxorubicin—pancreatic cancer	0.000209	0.0032	CcSEcCtD
Telaprevir—Blood uric acid increased—Epirubicin—pancreatic cancer	0.000208	0.00318	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Doxorubicin—pancreatic cancer	0.000208	0.00318	CcSEcCtD
Telaprevir—Hyperuricaemia—Doxorubicin—pancreatic cancer	0.000204	0.00311	CcSEcCtD
Telaprevir—Erythema multiforme—Gemcitabine—pancreatic cancer	0.000202	0.0031	CcSEcCtD
Telaprevir—CYP3A4—digestive system—pancreatic cancer	0.000202	0.00289	CbGeAlD
Telaprevir—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.000198	0.00302	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000196	0.003	CcSEcCtD
Telaprevir—Candida infection—Epirubicin—pancreatic cancer	0.000195	0.00298	CcSEcCtD
Telaprevir—Blood uric acid increased—Doxorubicin—pancreatic cancer	0.000192	0.00294	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000191	0.00292	CcSEcCtD
Telaprevir—Fatigue—Tamoxifen—pancreatic cancer	0.000191	0.00292	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000189	0.00289	CcSEcCtD
Telaprevir—Fatigue—Erlotinib—pancreatic cancer	0.000189	0.00289	CcSEcCtD
Telaprevir—Infection—Sunitinib—pancreatic cancer	0.000188	0.00288	CcSEcCtD
Telaprevir—Shock—Sunitinib—pancreatic cancer	0.000187	0.00285	CcSEcCtD
Telaprevir—Nervous system disorder—Sunitinib—pancreatic cancer	0.000186	0.00284	CcSEcCtD
Telaprevir—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000186	0.00284	CcSEcCtD
Telaprevir—Skin disorder—Sunitinib—pancreatic cancer	0.000184	0.00282	CcSEcCtD
Telaprevir—Candida infection—Doxorubicin—pancreatic cancer	0.00018	0.00276	CcSEcCtD
Telaprevir—Anaemia—Irinotecan—pancreatic cancer	0.000177	0.0027	CcSEcCtD
Telaprevir—Urticaria—Tamoxifen—pancreatic cancer	0.000176	0.00269	CcSEcCtD
Telaprevir—Anaemia—Gemcitabine—pancreatic cancer	0.000172	0.00263	CcSEcCtD
Telaprevir—Syncope—Irinotecan—pancreatic cancer	0.000172	0.00262	CcSEcCtD
Telaprevir—Anaemia—Fluorouracil—pancreatic cancer	0.000169	0.00259	CcSEcCtD
Telaprevir—Infestation NOS—Docetaxel—pancreatic cancer	0.000169	0.00259	CcSEcCtD
Telaprevir—Infestation—Docetaxel—pancreatic cancer	0.000169	0.00259	CcSEcCtD
Telaprevir—Loss of consciousness—Irinotecan—pancreatic cancer	0.000168	0.00257	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.000168	0.00257	CcSEcCtD
Telaprevir—ABCB1—pancreas—pancreatic cancer	0.000167	0.00239	CbGeAlD
Telaprevir—Eczema—Epirubicin—pancreatic cancer	0.000165	0.00252	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000164	0.0025	CcSEcCtD
Telaprevir—Fatigue—Sunitinib—pancreatic cancer	0.000163	0.0025	CcSEcCtD
Telaprevir—Renal failure acute—Epirubicin—pancreatic cancer	0.00016	0.00245	CcSEcCtD
Telaprevir—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.00016	0.00245	CcSEcCtD
Telaprevir—Asthenia—Tamoxifen—pancreatic cancer	0.000159	0.00243	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000158	0.00241	CcSEcCtD
Telaprevir—Asthenia—Erlotinib—pancreatic cancer	0.000157	0.0024	CcSEcCtD
Telaprevir—Pruritus—Tamoxifen—pancreatic cancer	0.000157	0.00239	CcSEcCtD
Telaprevir—Infection—Irinotecan—pancreatic cancer	0.000155	0.00237	CcSEcCtD
Telaprevir—Pruritus—Erlotinib—pancreatic cancer	0.000155	0.00237	CcSEcCtD
Telaprevir—Shock—Irinotecan—pancreatic cancer	0.000154	0.00235	CcSEcCtD
Telaprevir—Nervous system disorder—Irinotecan—pancreatic cancer	0.000153	0.00234	CcSEcCtD
Telaprevir—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000153	0.00234	CcSEcCtD
Telaprevir—Eczema—Doxorubicin—pancreatic cancer	0.000153	0.00233	CcSEcCtD
Telaprevir—Diarrhoea—Tamoxifen—pancreatic cancer	0.000151	0.00232	CcSEcCtD
Telaprevir—Infection—Gemcitabine—pancreatic cancer	0.000151	0.00231	CcSEcCtD
Telaprevir—Urinary tract disorder—Docetaxel—pancreatic cancer	0.00015	0.00229	CcSEcCtD
Telaprevir—Diarrhoea—Erlotinib—pancreatic cancer	0.00015	0.00229	CcSEcCtD
Telaprevir—Oedema peripheral—Docetaxel—pancreatic cancer	0.00015	0.00229	CcSEcCtD
Telaprevir—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000149	0.00228	CcSEcCtD
Telaprevir—Urethral disorder—Docetaxel—pancreatic cancer	0.000149	0.00228	CcSEcCtD
Telaprevir—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000149	0.00228	CcSEcCtD
Telaprevir—Infection—Fluorouracil—pancreatic cancer	0.000149	0.00227	CcSEcCtD
Telaprevir—Renal failure acute—Doxorubicin—pancreatic cancer	0.000148	0.00227	CcSEcCtD
Telaprevir—Skin disorder—Gemcitabine—pancreatic cancer	0.000148	0.00226	CcSEcCtD
Telaprevir—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000147	0.00224	CcSEcCtD
Telaprevir—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000146	0.00224	CcSEcCtD
Telaprevir—Dizziness—Tamoxifen—pancreatic cancer	0.000146	0.00224	CcSEcCtD
Telaprevir—Dizziness—Erlotinib—pancreatic cancer	0.000145	0.00221	CcSEcCtD
Telaprevir—Erythema multiforme—Docetaxel—pancreatic cancer	0.000144	0.0022	CcSEcCtD
Telaprevir—ABCB1—digestive system—pancreatic cancer	0.000143	0.00204	CbGeAlD
Telaprevir—Eye disorder—Docetaxel—pancreatic cancer	0.000142	0.00217	CcSEcCtD
Telaprevir—Vomiting—Tamoxifen—pancreatic cancer	0.000141	0.00215	CcSEcCtD
Telaprevir—Rash—Tamoxifen—pancreatic cancer	0.00014	0.00213	CcSEcCtD
Telaprevir—Dermatitis—Tamoxifen—pancreatic cancer	0.000139	0.00213	CcSEcCtD
Telaprevir—Vomiting—Erlotinib—pancreatic cancer	0.000139	0.00213	CcSEcCtD
Telaprevir—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000139	0.00212	CcSEcCtD
Telaprevir—Rash—Erlotinib—pancreatic cancer	0.000138	0.00211	CcSEcCtD
Telaprevir—Dermatitis—Erlotinib—pancreatic cancer	0.000138	0.00211	CcSEcCtD
Telaprevir—Asthenia—Sunitinib—pancreatic cancer	0.000136	0.00208	CcSEcCtD
Telaprevir—Hypokalaemia—Epirubicin—pancreatic cancer	0.000135	0.00206	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000135	0.00206	CcSEcCtD
Telaprevir—Fatigue—Irinotecan—pancreatic cancer	0.000135	0.00206	CcSEcCtD
Telaprevir—Pruritus—Sunitinib—pancreatic cancer	0.000134	0.00205	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000133	0.00204	CcSEcCtD
Telaprevir—Malnutrition—Docetaxel—pancreatic cancer	0.000132	0.00202	CcSEcCtD
Telaprevir—Nausea—Tamoxifen—pancreatic cancer	0.000131	0.00201	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000131	0.00201	CcSEcCtD
Telaprevir—Fatigue—Gemcitabine—pancreatic cancer	0.000131	0.00201	CcSEcCtD
Telaprevir—Nausea—Erlotinib—pancreatic cancer	0.00013	0.00199	CcSEcCtD
Telaprevir—Diarrhoea—Sunitinib—pancreatic cancer	0.00013	0.00198	CcSEcCtD
Telaprevir—Dysgeusia—Docetaxel—pancreatic cancer	0.00013	0.00198	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000129	0.00197	CcSEcCtD
Telaprevir—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000128	0.00196	CcSEcCtD
Telaprevir—Eosinophilia—Epirubicin—pancreatic cancer	0.000127	0.00194	CcSEcCtD
Telaprevir—Dizziness—Sunitinib—pancreatic cancer	0.000125	0.00192	CcSEcCtD
Telaprevir—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000125	0.00191	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000123	0.00189	CcSEcCtD
Telaprevir—Anaemia—Docetaxel—pancreatic cancer	0.000122	0.00187	CcSEcCtD
Telaprevir—Vomiting—Sunitinib—pancreatic cancer	0.000121	0.00184	CcSEcCtD
Telaprevir—Rash—Sunitinib—pancreatic cancer	0.00012	0.00183	CcSEcCtD
Telaprevir—Dermatitis—Sunitinib—pancreatic cancer	0.000119	0.00183	CcSEcCtD
Telaprevir—Urticaria—Fluorouracil—pancreatic cancer	0.000119	0.00182	CcSEcCtD
Telaprevir—Syncope—Docetaxel—pancreatic cancer	0.000119	0.00181	CcSEcCtD
Telaprevir—Eosinophilia—Doxorubicin—pancreatic cancer	0.000117	0.00179	CcSEcCtD
Telaprevir—Loss of consciousness—Docetaxel—pancreatic cancer	0.000116	0.00178	CcSEcCtD
Telaprevir—Infestation NOS—Epirubicin—pancreatic cancer	0.000114	0.00175	CcSEcCtD
Telaprevir—Infestation—Epirubicin—pancreatic cancer	0.000114	0.00175	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000113	0.00173	CcSEcCtD
Telaprevir—Nausea—Sunitinib—pancreatic cancer	0.000113	0.00172	CcSEcCtD
Telaprevir—Asthenia—Irinotecan—pancreatic cancer	0.000112	0.00171	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000112	0.00171	CcSEcCtD
Telaprevir—Asthenia—Gemcitabine—pancreatic cancer	0.000109	0.00167	CcSEcCtD
Telaprevir—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000108	0.00165	CcSEcCtD
Telaprevir—Pruritus—Gemcitabine—pancreatic cancer	0.000108	0.00165	CcSEcCtD
Telaprevir—Infection—Docetaxel—pancreatic cancer	0.000107	0.00164	CcSEcCtD
Telaprevir—Diarrhoea—Irinotecan—pancreatic cancer	0.000107	0.00163	CcSEcCtD
Telaprevir—Shock—Docetaxel—pancreatic cancer	0.000106	0.00162	CcSEcCtD
Telaprevir—Nervous system disorder—Docetaxel—pancreatic cancer	0.000106	0.00162	CcSEcCtD
Telaprevir—Pruritus—Fluorouracil—pancreatic cancer	0.000106	0.00162	CcSEcCtD
Telaprevir—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000106	0.00162	CcSEcCtD
Telaprevir—Infestation NOS—Doxorubicin—pancreatic cancer	0.000106	0.00162	CcSEcCtD
Telaprevir—Infestation—Doxorubicin—pancreatic cancer	0.000106	0.00162	CcSEcCtD
Telaprevir—Skin disorder—Docetaxel—pancreatic cancer	0.000105	0.0016	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000105	0.0016	CcSEcCtD
Telaprevir—Diarrhoea—Gemcitabine—pancreatic cancer	0.000104	0.00159	CcSEcCtD
Telaprevir—Dizziness—Irinotecan—pancreatic cancer	0.000103	0.00158	CcSEcCtD
Telaprevir—Diarrhoea—Fluorouracil—pancreatic cancer	0.000102	0.00156	CcSEcCtD
Telaprevir—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000101	0.00155	CcSEcCtD
Telaprevir—Oedema peripheral—Epirubicin—pancreatic cancer	0.000101	0.00154	CcSEcCtD
Telaprevir—Urethral disorder—Epirubicin—pancreatic cancer	0.0001	0.00154	CcSEcCtD
Telaprevir—Hepatobiliary disease—Doxorubicin—pancreatic cancer	9.99e-05	0.00153	CcSEcCtD
Telaprevir—Vomiting—Irinotecan—pancreatic cancer	9.93e-05	0.00152	CcSEcCtD
Telaprevir—Dizziness—Fluorouracil—pancreatic cancer	9.89e-05	0.00151	CcSEcCtD
Telaprevir—Rash—Irinotecan—pancreatic cancer	9.85e-05	0.00151	CcSEcCtD
Telaprevir—Dermatitis—Irinotecan—pancreatic cancer	9.84e-05	0.0015	CcSEcCtD
Telaprevir—Erythema multiforme—Epirubicin—pancreatic cancer	9.69e-05	0.00148	CcSEcCtD
Telaprevir—Vomiting—Gemcitabine—pancreatic cancer	9.67e-05	0.00148	CcSEcCtD
Telaprevir—Rash—Gemcitabine—pancreatic cancer	9.59e-05	0.00147	CcSEcCtD
Telaprevir—Dermatitis—Gemcitabine—pancreatic cancer	9.58e-05	0.00147	CcSEcCtD
Telaprevir—Eye disorder—Epirubicin—pancreatic cancer	9.58e-05	0.00146	CcSEcCtD
Telaprevir—Vomiting—Fluorouracil—pancreatic cancer	9.51e-05	0.00145	CcSEcCtD
Telaprevir—Rash—Fluorouracil—pancreatic cancer	9.43e-05	0.00144	CcSEcCtD
Telaprevir—Dermatitis—Fluorouracil—pancreatic cancer	9.42e-05	0.00144	CcSEcCtD
Telaprevir—Urinary tract disorder—Doxorubicin—pancreatic cancer	9.37e-05	0.00143	CcSEcCtD
Telaprevir—Oedema peripheral—Doxorubicin—pancreatic cancer	9.34e-05	0.00143	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Docetaxel—pancreatic cancer	9.32e-05	0.00143	CcSEcCtD
Telaprevir—Fatigue—Docetaxel—pancreatic cancer	9.31e-05	0.00142	CcSEcCtD
Telaprevir—Urethral disorder—Doxorubicin—pancreatic cancer	9.3e-05	0.00142	CcSEcCtD
Telaprevir—Nausea—Irinotecan—pancreatic cancer	9.28e-05	0.00142	CcSEcCtD
Telaprevir—Nausea—Gemcitabine—pancreatic cancer	9.04e-05	0.00138	CcSEcCtD
Telaprevir—Erythema multiforme—Doxorubicin—pancreatic cancer	8.97e-05	0.00137	CcSEcCtD
Telaprevir—Malnutrition—Epirubicin—pancreatic cancer	8.92e-05	0.00136	CcSEcCtD
Telaprevir—Nausea—Fluorouracil—pancreatic cancer	8.88e-05	0.00136	CcSEcCtD
Telaprevir—Eye disorder—Doxorubicin—pancreatic cancer	8.86e-05	0.00136	CcSEcCtD
Telaprevir—Dysgeusia—Epirubicin—pancreatic cancer	8.74e-05	0.00134	CcSEcCtD
Telaprevir—Malnutrition—Doxorubicin—pancreatic cancer	8.26e-05	0.00126	CcSEcCtD
Telaprevir—Anaemia—Epirubicin—pancreatic cancer	8.25e-05	0.00126	CcSEcCtD
Telaprevir—Dysgeusia—Doxorubicin—pancreatic cancer	8.08e-05	0.00124	CcSEcCtD
Telaprevir—Syncope—Epirubicin—pancreatic cancer	8e-05	0.00122	CcSEcCtD
Telaprevir—Loss of consciousness—Epirubicin—pancreatic cancer	7.84e-05	0.0012	CcSEcCtD
Telaprevir—Asthenia—Docetaxel—pancreatic cancer	7.75e-05	0.00118	CcSEcCtD
Telaprevir—Pruritus—Docetaxel—pancreatic cancer	7.64e-05	0.00117	CcSEcCtD
Telaprevir—Anaemia—Doxorubicin—pancreatic cancer	7.63e-05	0.00117	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	7.54e-05	0.00115	CcSEcCtD
Telaprevir—Syncope—Doxorubicin—pancreatic cancer	7.4e-05	0.00113	CcSEcCtD
Telaprevir—Diarrhoea—Docetaxel—pancreatic cancer	7.39e-05	0.00113	CcSEcCtD
Telaprevir—Loss of consciousness—Doxorubicin—pancreatic cancer	7.26e-05	0.00111	CcSEcCtD
Telaprevir—Infection—Epirubicin—pancreatic cancer	7.23e-05	0.00111	CcSEcCtD
Telaprevir—Shock—Epirubicin—pancreatic cancer	7.16e-05	0.0011	CcSEcCtD
Telaprevir—Nervous system disorder—Epirubicin—pancreatic cancer	7.14e-05	0.00109	CcSEcCtD
Telaprevir—Dizziness—Docetaxel—pancreatic cancer	7.14e-05	0.00109	CcSEcCtD
Telaprevir—Thrombocytopenia—Epirubicin—pancreatic cancer	7.13e-05	0.00109	CcSEcCtD
Telaprevir—Skin disorder—Epirubicin—pancreatic cancer	7.07e-05	0.00108	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	6.98e-05	0.00107	CcSEcCtD
Telaprevir—Vomiting—Docetaxel—pancreatic cancer	6.86e-05	0.00105	CcSEcCtD
Telaprevir—Rash—Docetaxel—pancreatic cancer	6.81e-05	0.00104	CcSEcCtD
Telaprevir—Dermatitis—Docetaxel—pancreatic cancer	6.8e-05	0.00104	CcSEcCtD
Telaprevir—Infection—Doxorubicin—pancreatic cancer	6.69e-05	0.00102	CcSEcCtD
Telaprevir—Shock—Doxorubicin—pancreatic cancer	6.63e-05	0.00101	CcSEcCtD
Telaprevir—Nervous system disorder—Doxorubicin—pancreatic cancer	6.61e-05	0.00101	CcSEcCtD
Telaprevir—Thrombocytopenia—Doxorubicin—pancreatic cancer	6.6e-05	0.00101	CcSEcCtD
Telaprevir—Skin disorder—Doxorubicin—pancreatic cancer	6.54e-05	0.001	CcSEcCtD
Telaprevir—Nausea—Docetaxel—pancreatic cancer	6.41e-05	0.000981	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Epirubicin—pancreatic cancer	6.29e-05	0.000961	CcSEcCtD
Telaprevir—Fatigue—Epirubicin—pancreatic cancer	6.28e-05	0.00096	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	5.82e-05	0.000889	CcSEcCtD
Telaprevir—Fatigue—Doxorubicin—pancreatic cancer	5.81e-05	0.000888	CcSEcCtD
Telaprevir—Urticaria—Epirubicin—pancreatic cancer	5.78e-05	0.000885	CcSEcCtD
Telaprevir—Urticaria—Doxorubicin—pancreatic cancer	5.35e-05	0.000818	CcSEcCtD
Telaprevir—Asthenia—Epirubicin—pancreatic cancer	5.22e-05	0.000799	CcSEcCtD
Telaprevir—Pruritus—Epirubicin—pancreatic cancer	5.15e-05	0.000788	CcSEcCtD
Telaprevir—Diarrhoea—Epirubicin—pancreatic cancer	4.98e-05	0.000762	CcSEcCtD
Telaprevir—Asthenia—Doxorubicin—pancreatic cancer	4.83e-05	0.000739	CcSEcCtD
Telaprevir—Dizziness—Epirubicin—pancreatic cancer	4.82e-05	0.000736	CcSEcCtD
Telaprevir—Pruritus—Doxorubicin—pancreatic cancer	4.77e-05	0.000729	CcSEcCtD
Telaprevir—Vomiting—Epirubicin—pancreatic cancer	4.63e-05	0.000708	CcSEcCtD
Telaprevir—Diarrhoea—Doxorubicin—pancreatic cancer	4.61e-05	0.000705	CcSEcCtD
Telaprevir—Rash—Epirubicin—pancreatic cancer	4.59e-05	0.000702	CcSEcCtD
Telaprevir—Dermatitis—Epirubicin—pancreatic cancer	4.59e-05	0.000701	CcSEcCtD
Telaprevir—Dizziness—Doxorubicin—pancreatic cancer	4.46e-05	0.000681	CcSEcCtD
Telaprevir—Nausea—Epirubicin—pancreatic cancer	4.33e-05	0.000661	CcSEcCtD
Telaprevir—Vomiting—Doxorubicin—pancreatic cancer	4.28e-05	0.000655	CcSEcCtD
Telaprevir—Rash—Doxorubicin—pancreatic cancer	4.25e-05	0.00065	CcSEcCtD
Telaprevir—Dermatitis—Doxorubicin—pancreatic cancer	4.24e-05	0.000649	CcSEcCtD
Telaprevir—CTSK—Adaptive Immune System—PIK3CB—pancreatic cancer	4.06e-05	0.00104	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CDH1—pancreatic cancer	4.02e-05	0.00103	CbGpPWpGaD
Telaprevir—Nausea—Doxorubicin—pancreatic cancer	4e-05	0.000612	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—PIK3CD—pancreatic cancer	4e-05	0.00102	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—CXCL8—pancreatic cancer	3.98e-05	0.00102	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	3.95e-05	0.00101	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—GCG—pancreatic cancer	3.93e-05	0.00101	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—EGF—pancreatic cancer	3.91e-05	0.001	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	3.91e-05	0.001	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—PIK3CD—pancreatic cancer	3.84e-05	0.000983	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—CTNNB1—pancreatic cancer	3.75e-05	0.00096	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—AGTR1—pancreatic cancer	3.75e-05	0.00096	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—STK11—pancreatic cancer	3.69e-05	0.000946	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—CTNNB1—pancreatic cancer	3.68e-05	0.000942	CbGpPWpGaD
Telaprevir—ALB—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	3.67e-05	0.00094	CbGpPWpGaD
Telaprevir—CTSK—Immune System—BCL2L1—pancreatic cancer	3.66e-05	0.000938	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—PTEN—pancreatic cancer	3.65e-05	0.000936	CbGpPWpGaD
Telaprevir—CTSK—Immune System—TSC2—pancreatic cancer	3.64e-05	0.000932	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—PTEN—pancreatic cancer	3.51e-05	0.000899	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—PIK3CB—pancreatic cancer	3.48e-05	0.000892	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	3.41e-05	0.000874	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—SRC—pancreatic cancer	3.39e-05	0.000868	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	3.36e-05	0.00086	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—PIK3CB—pancreatic cancer	3.34e-05	0.000857	CbGpPWpGaD
Telaprevir—CTSK—Immune System—NFKBIA—pancreatic cancer	3.32e-05	0.00085	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—NRAS—pancreatic cancer	3.26e-05	0.000835	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—SRC—pancreatic cancer	3.25e-05	0.000834	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SMAD4—pancreatic cancer	3.23e-05	0.000829	CbGpPWpGaD
Telaprevir—CTSK—Immune System—EGF—pancreatic cancer	3.18e-05	0.000814	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HES1—pancreatic cancer	3.16e-05	0.000809	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—NRAS—pancreatic cancer	3.13e-05	0.000802	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—CTNNB1—pancreatic cancer	3.09e-05	0.000791	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—TNF—pancreatic cancer	3.05e-05	0.000782	CbGpPWpGaD
Telaprevir—CTSS—Immune System—BCL2L1—pancreatic cancer	3.02e-05	0.000773	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—PTEN—pancreatic cancer	3.01e-05	0.000771	CbGpPWpGaD
Telaprevir—CTSS—Immune System—TSC2—pancreatic cancer	3e-05	0.000768	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—EGFR—pancreatic cancer	2.97e-05	0.000761	CbGpPWpGaD
Telaprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	2.96e-05	0.000759	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CDH1—pancreatic cancer	2.96e-05	0.000758	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IFNA5—pancreatic cancer	2.95e-05	0.000756	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—PTGS2—pancreatic cancer	2.92e-05	0.000748	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—PTEN—pancreatic cancer	2.89e-05	0.00074	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	2.87e-05	0.000736	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—EGFR—pancreatic cancer	2.85e-05	0.000731	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PIK3CD—pancreatic cancer	2.83e-05	0.000724	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—KRAS—pancreatic cancer	2.81e-05	0.000719	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—SRC—pancreatic cancer	2.79e-05	0.000715	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PPP2R5B—pancreatic cancer	2.79e-05	0.000714	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TERT—pancreatic cancer	2.77e-05	0.000709	CbGpPWpGaD
Telaprevir—CTSS—Immune System—NFKBIA—pancreatic cancer	2.73e-05	0.0007	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	2.71e-05	0.000693	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—KRAS—pancreatic cancer	2.69e-05	0.00069	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—NRAS—pancreatic cancer	2.68e-05	0.000688	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—SRC—pancreatic cancer	2.68e-05	0.000686	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HIF1A—pancreatic cancer	2.65e-05	0.000678	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TSC2—pancreatic cancer	2.64e-05	0.000676	CbGpPWpGaD
Telaprevir—CTSS—Immune System—EGF—pancreatic cancer	2.62e-05	0.00067	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	2.6e-05	0.000666	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	2.59e-05	0.000664	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—APOE—pancreatic cancer	2.58e-05	0.000662	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—NRAS—pancreatic cancer	2.58e-05	0.00066	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—PIK3CA—pancreatic cancer	2.58e-05	0.00066	CbGpPWpGaD
Telaprevir—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	2.56e-05	0.000655	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	2.54e-05	0.00065	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—KDR—pancreatic cancer	2.53e-05	0.000648	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	2.52e-05	0.000645	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—VEGFA—pancreatic cancer	2.48e-05	0.000636	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TNF—pancreatic cancer	2.48e-05	0.000636	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—PIK3CA—pancreatic cancer	2.48e-05	0.000634	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	2.47e-05	0.000633	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PIK3CB—pancreatic cancer	2.46e-05	0.000631	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—EGFR—pancreatic cancer	2.45e-05	0.000627	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CDH1—pancreatic cancer	2.44e-05	0.000624	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NFKBIA—pancreatic cancer	2.41e-05	0.000617	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—HRAS—pancreatic cancer	2.39e-05	0.000611	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NOTCH1—pancreatic cancer	2.38e-05	0.000611	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—pancreatic cancer	2.37e-05	0.000606	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—EGFR—pancreatic cancer	2.35e-05	0.000602	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PIK3CG—pancreatic cancer	2.33e-05	0.000597	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PIK3CD—pancreatic cancer	2.33e-05	0.000596	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—KRAS—pancreatic cancer	2.31e-05	0.000592	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EGF—pancreatic cancer	2.31e-05	0.00059	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—HRAS—pancreatic cancer	2.29e-05	0.000587	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—TGFB1—pancreatic cancer	2.28e-05	0.000584	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—KRAS—pancreatic cancer	2.22e-05	0.000568	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	2.2e-05	0.000563	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TP53—pancreatic cancer	2.19e-05	0.000561	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CTNNB1—pancreatic cancer	2.18e-05	0.000559	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatic cancer	2.17e-05	0.000556	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PTEN—pancreatic cancer	2.13e-05	0.000545	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—PIK3CA—pancreatic cancer	2.12e-05	0.000544	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—AKT1—pancreatic cancer	2.11e-05	0.000539	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PIK3CD—pancreatic cancer	2.05e-05	0.000525	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—PIK3CA—pancreatic cancer	2.04e-05	0.000522	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PIK3CB—pancreatic cancer	2.03e-05	0.00052	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—AKT1—pancreatic cancer	2.02e-05	0.000518	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	2.02e-05	0.000517	CbGpPWpGaD
Telaprevir—CTSK—Immune System—SRC—pancreatic cancer	1.97e-05	0.000506	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—TNF—pancreatic cancer	1.97e-05	0.000505	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—HRAS—pancreatic cancer	1.96e-05	0.000503	CbGpPWpGaD
Telaprevir—CTSK—Immune System—STAT3—pancreatic cancer	1.9e-05	0.000488	CbGpPWpGaD
Telaprevir—CTSK—Immune System—NRAS—pancreatic cancer	1.9e-05	0.000486	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—HRAS—pancreatic cancer	1.89e-05	0.000483	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—TNF—pancreatic cancer	1.88e-05	0.000483	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	1.87e-05	0.00048	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.87e-05	0.000478	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	1.84e-05	0.000472	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	1.82e-05	0.000466	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CTNNB1—pancreatic cancer	1.8e-05	0.000461	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	1.79e-05	0.000459	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PIK3CB—pancreatic cancer	1.79e-05	0.000458	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PTEN—pancreatic cancer	1.75e-05	0.000449	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—AKT1—pancreatic cancer	1.73e-05	0.000444	CbGpPWpGaD
Telaprevir—CTSK—Immune System—EGFR—pancreatic cancer	1.73e-05	0.000443	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CXCL8—pancreatic cancer	1.72e-05	0.00044	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—CD44—pancreatic cancer	1.67e-05	0.000427	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—AKT1—pancreatic cancer	1.67e-05	0.000427	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CASP3—pancreatic cancer	1.64e-05	0.000421	CbGpPWpGaD
Telaprevir—CTSK—Immune System—KRAS—pancreatic cancer	1.63e-05	0.000419	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.63e-05	0.000419	CbGpPWpGaD
Telaprevir—CTSS—Immune System—SRC—pancreatic cancer	1.63e-05	0.000416	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	1.62e-05	0.000415	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	1.62e-05	0.000415	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IFNA1—pancreatic cancer	1.62e-05	0.000414	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CCND1—pancreatic cancer	1.6e-05	0.00041	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CTNNB1—pancreatic cancer	1.58e-05	0.000406	CbGpPWpGaD
Telaprevir—CTSS—Immune System—STAT3—pancreatic cancer	1.57e-05	0.000402	CbGpPWpGaD
Telaprevir—CTSS—Immune System—NRAS—pancreatic cancer	1.56e-05	0.000401	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MMP9—pancreatic cancer	1.55e-05	0.000398	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PTEN—pancreatic cancer	1.54e-05	0.000395	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PRSS1—pancreatic cancer	1.53e-05	0.000392	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IFNA2—pancreatic cancer	1.5e-05	0.000385	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PIK3CA—pancreatic cancer	1.5e-05	0.000385	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SRC—pancreatic cancer	1.43e-05	0.000367	CbGpPWpGaD
Telaprevir—CTSS—Immune System—EGFR—pancreatic cancer	1.42e-05	0.000365	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	1.41e-05	0.000362	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—VEGFA—pancreatic cancer	1.39e-05	0.000357	CbGpPWpGaD
Telaprevir—CTSK—Immune System—HRAS—pancreatic cancer	1.39e-05	0.000356	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—STAT3—pancreatic cancer	1.38e-05	0.000354	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NRAS—pancreatic cancer	1.38e-05	0.000353	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	1.38e-05	0.000353	CbGpPWpGaD
Telaprevir—CTSS—Immune System—KRAS—pancreatic cancer	1.35e-05	0.000345	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PRSS1—pancreatic cancer	1.34e-05	0.000344	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ARG2—pancreatic cancer	1.33e-05	0.00034	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MYC—pancreatic cancer	1.28e-05	0.000329	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TGFB1—pancreatic cancer	1.28e-05	0.000328	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	1.28e-05	0.000328	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EGFR—pancreatic cancer	1.26e-05	0.000321	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	1.24e-05	0.000319	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PIK3CA—pancreatic cancer	1.24e-05	0.000317	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	1.23e-05	0.000316	CbGpPWpGaD
Telaprevir—CTSK—Immune System—AKT1—pancreatic cancer	1.23e-05	0.000314	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.2e-05	0.000308	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—KRAS—pancreatic cancer	1.19e-05	0.000304	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ARG2—pancreatic cancer	1.16e-05	0.000298	CbGpPWpGaD
Telaprevir—ALB—Metabolism—TYMP—pancreatic cancer	1.16e-05	0.000297	CbGpPWpGaD
Telaprevir—CTSS—Immune System—HRAS—pancreatic cancer	1.14e-05	0.000293	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	1.13e-05	0.00029	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.11e-05	0.000285	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	1.1e-05	0.000282	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PIK3CA—pancreatic cancer	1.09e-05	0.000279	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.08e-05	0.000278	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PLAU—pancreatic cancer	1.07e-05	0.000273	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TP53—pancreatic cancer	1.05e-05	0.00027	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TYMP—pancreatic cancer	1.02e-05	0.000261	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	1.01e-05	0.000259	CbGpPWpGaD
Telaprevir—CTSS—Immune System—AKT1—pancreatic cancer	1.01e-05	0.000259	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HRAS—pancreatic cancer	1.01e-05	0.000258	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	9.98e-06	0.000256	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	9.96e-06	0.000255	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	9.76e-06	0.00025	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.58e-06	0.000245	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CG—pancreatic cancer	9.5e-06	0.000243	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—EGF—pancreatic cancer	9.39e-06	0.00024	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GLP1R—pancreatic cancer	9.36e-06	0.00024	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	9.3e-06	0.000238	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	9.22e-06	0.000236	CbGpPWpGaD
Telaprevir—ALB—Metabolism—DPYD—pancreatic cancer	9.21e-06	0.000236	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—AKT1—pancreatic cancer	8.9e-06	0.000228	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC2A2—pancreatic cancer	8.74e-06	0.000224	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.65e-06	0.000221	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	8.61e-06	0.00022	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	8.47e-06	0.000217	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CD—pancreatic cancer	8.35e-06	0.000214	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.34e-06	0.000214	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PRSS1—pancreatic cancer	8.27e-06	0.000212	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GLP1R—pancreatic cancer	8.2e-06	0.00021	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	8.2e-06	0.00021	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—DPYD—pancreatic cancer	8.07e-06	0.000207	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC2A2—pancreatic cancer	7.65e-06	0.000196	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.6e-06	0.000195	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CB—pancreatic cancer	7.28e-06	0.000186	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ARG2—pancreatic cancer	7.17e-06	0.000184	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	7.03e-06	0.00018	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	6.92e-06	0.000177	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CD44—pancreatic cancer	6.77e-06	0.000173	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.63e-06	0.00017	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.56e-06	0.000168	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GCG—pancreatic cancer	6.49e-06	0.000166	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TYMP—pancreatic cancer	6.27e-06	0.000161	CbGpPWpGaD
Telaprevir—ALB—Metabolism—STK11—pancreatic cancer	6.1e-06	0.000156	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CD44—pancreatic cancer	5.93e-06	0.000152	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—SRC—pancreatic cancer	5.83e-06	0.000149	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.72e-06	0.000147	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GCG—pancreatic cancer	5.68e-06	0.000146	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—VEGFA—pancreatic cancer	5.68e-06	0.000145	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NRAS—pancreatic cancer	5.61e-06	0.000144	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—STK11—pancreatic cancer	5.34e-06	0.000137	CbGpPWpGaD
Telaprevir—ALB—Metabolism—TYMS—pancreatic cancer	5.25e-06	0.000134	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TGFB1—pancreatic cancer	5.21e-06	0.000134	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GLP1R—pancreatic cancer	5.05e-06	0.000129	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—DPYD—pancreatic cancer	4.97e-06	0.000127	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—KRAS—pancreatic cancer	4.83e-06	0.000124	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	4.72e-06	0.000121	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TYMS—pancreatic cancer	4.6e-06	0.000118	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CA—pancreatic cancer	4.44e-06	0.000114	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TP53—pancreatic cancer	4.29e-06	0.00011	CbGpPWpGaD
Telaprevir—ALB—Metabolism—APOE—pancreatic cancer	4.27e-06	0.000109	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—HRAS—pancreatic cancer	4.1e-06	0.000105	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.04e-06	0.000103	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CG—pancreatic cancer	3.85e-06	9.86e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—APOE—pancreatic cancer	3.74e-06	9.58e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PPARG—pancreatic cancer	3.72e-06	9.52e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CD44—pancreatic cancer	3.65e-06	9.36e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—AKT1—pancreatic cancer	3.62e-06	9.28e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GCG—pancreatic cancer	3.5e-06	8.97e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CD—pancreatic cancer	3.39e-06	8.67e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CG—pancreatic cancer	3.37e-06	8.64e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—STK11—pancreatic cancer	3.29e-06	8.43e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PPARG—pancreatic cancer	3.26e-06	8.34e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CD—pancreatic cancer	2.97e-06	7.6e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CB—pancreatic cancer	2.95e-06	7.56e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTGS2—pancreatic cancer	2.92e-06	7.49e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.83e-06	7.25e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CB—pancreatic cancer	2.59e-06	6.62e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTGS2—pancreatic cancer	2.56e-06	6.56e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTEN—pancreatic cancer	2.55e-06	6.53e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—APOE—pancreatic cancer	2.3e-06	5.9e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTEN—pancreatic cancer	2.23e-06	5.72e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.08e-06	5.32e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.01e-06	5.14e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.83e-06	4.68e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CA—pancreatic cancer	1.8e-06	4.61e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.59e-06	4.08e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.58e-06	4.04e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.58e-06	4.04e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—AKT1—pancreatic cancer	1.47e-06	3.76e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.38e-06	3.53e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—AKT1—pancreatic cancer	1.29e-06	3.3e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	9.71e-07	2.49e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AKT1—pancreatic cancer	7.93e-07	2.03e-05	CbGpPWpGaD
